Novo Nordisk

NVO

#385

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Who are the different issuers of tokenized Novo Nordisk (NVO)?

There are currently 2 issuers of tokenized Novo Nordisk on CoinGecko. Ondo Finance's NVOON is the most popular Novo Nordisk tokenized stock with a market cap of $2.46M, followed by xStocks's NVOX with a market cap of $601.95K.

What is the daily trading volume of tokenized Novo Nordisk (NVO)?

The trading volume of tokenized Novo Nordisk (NVO) is $406.44K in the last 24 hours, up 1.38% from the previous day. The most traded NVO tokenized stock is Ondo Finance's NVOON, accounting for 100% of total volume.

Where can I buy tokenized Novo Nordisk (NVO)?

Tokenized Novo Nordisk (NVO) can be traded on centralized exchanges. The most popular exchange to buy and trade tokenized NVO is LBank, where the most active trading pair NVOON/USDT has a trading volume of $345.49K in the last 24 hours. Other popular options include MEXC and Ondo Stocks.